DAIHAN Scientific Co. Ltd (131220) — Capital Reinvestment Ratio
DAIHAN Scientific Co. Ltd (131220) has a Capital Reinvestment Ratio of 0.48x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩361.12 Million) in capital expenditures (₩174.87 Million). Check 131220 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DAIHAN Scientific Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks DAIHAN Scientific Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see DAIHAN Scientific Co. Ltd (131220) cash flow conversion.
Annual Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for DAIHAN Scientific Co. Ltd from 2012 to 2024. See DAIHAN Scientific Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.12x | ₩3.99 Billion | ₩494.10 Million | ▼ -8.0% |
| 2023 | 0.13x | ₩4.79 Billion | ₩645.76 Million | ▼ -80.0% |
| 2022 | 0.67x | ₩4.51 Billion | ₩3.04 Billion | ▼ -12.8% |
| 2021 | 0.77x | ₩4.13 Billion | ₩3.19 Billion | ▲ +317.8% |
| 2020 | 0.18x | ₩5.35 Billion | ₩988.48 Million | ▼ -52.0% |
| 2019 | 0.39x | ₩2.44 Billion | ₩939.56 Million | ▼ -14.5% |
| 2018 | 0.45x | ₩3.76 Billion | ₩1.69 Billion | ▲ +199.4% |
| 2017 | 0.15x | ₩4.58 Billion | ₩689.55 Million | ▲ +4.2% |
| 2016 | 0.14x | ₩4.12 Billion | ₩595.73 Million | ▼ -88.3% |
| 2015 | 1.23x | ₩898.12 Million | ₩1.11 Billion | ▲ +644.7% |
| 2014 | 0.17x | ₩2.59 Billion | ₩429.31 Million | ▼ -89.7% |
| 2012 | 1.61x | ₩565.94 Million | ₩909.46 Million | — |